PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION STATUS IN PENILE SQUAMOUS CELL CARCINOMA TUMOR CELLS AND TUMOR INFILTRATING IMMUNE CELLS

被引：0
|
作者：
Rider, Jennifer
Harlow, Alyssa
Giunchi, Francesca
Carlsson, Jessica
Kirrander, Peter
Fiorentino, Michelangelo
Andren, Ove
Davidsson, Sabina
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP84-13
引用
收藏
页码：E1129 / E1130
页数：2
相关论文
共 50 条
  • [1] Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma
    Wang, Jennifer
    Rodriguez, Jaime
    Rao, Priya
    Pettaway, Curtis Alvin
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] Programmed Death Ligand-1 (PD-L1) Status in North American Cohort of Penile Squamous Cell Carcinoma
    Cocks, Margaret
    Taheri, Diana
    Ball, Mark W.
    Bezerra, Stephania M.
    Rodriguez, Maria D. C.
    Meeker, Alan
    Bivalacqua, Trinity J.
    Chaux, Alcides
    Burnett, Arthur
    Netto, Geoige J.
    MODERN PATHOLOGY, 2016, 29 : 222A - 222A
  • [3] PROGRAMMED DEATH LIGAND-1 (PD-L1) STATUS IN NORTH AMERICAN COHORT OF PENILE SQUAMOUS CELL CARCINOMA
    Cocks, Margaret
    Taheri, Diana
    Ball, Mark W.
    Bezerra, Stephania M.
    Meeker, Alan
    Rodriguez, Maria Del Carmen
    Chaux, Alcides
    Burnett, Arthur
    Netto, George
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1060 - E1060
  • [4] Programmed Death Ligand-1 (PD-L1) Status in North American Cohort of Penile Squamous Cell Carcinoma
    Cocks, Margaret
    Taheri, Diana
    Ball, Mark W.
    Bezerra, Stephania M.
    Rodriguez, Maria D. C.
    Meeker, Alan
    Bivalacqua, Trinity J.
    Chaux, Alcides
    Burnett, Arthur
    Netto, George J.
    LABORATORY INVESTIGATION, 2016, 96 : 222A - 222A
  • [5] Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas
    Driver, Brandon R.
    Miller, Ross A.
    Miller, Tara
    Deavers, Michael
    Gorman, Blythe
    Mody, Dina
    Ge, Yimin
    Barrios, Roberto
    Bernicker, Eric
    Kim, Min
    Cagle, Philip T.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (11) : 1529 - 1532
  • [6] Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance
    Mondal, Santosh Kumar
    Bhattacharya, Saptarshi
    Sarkar, Aditya Prasad
    Saha, Rama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S81 - S86
  • [7] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [8] Expression of Programmed Death-Ligand 1 and 2 (PD-L1/2) on Tumor cells of Oropharyngeal Squamous Cell Carcinoma (OPSCC)
    Wuerdemann, N.
    Gueltekin, S. E.
    Wittekindt, C.
    Sharma, S. J.
    Schubotz, A. B.
    Gattenloehner, S.
    Tharun, L.
    Baris, E.
    Sengueven, B.
    Yildirim, B.
    Buettner, R.
    Speel, E. -J.
    Wagner, S.
    Klussmann, J. -P.
    Quaas, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 95 - 95
  • [9] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [10] Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma
    Jiang, Yubo
    Lo, Anthony W. I.
    Wong, Angela
    Chen, Wenfeng
    Wang, Yan
    Lin, Li
    Xu, Jianming
    ONCOTARGET, 2017, 8 (18) : 30175 - 30189
12345